CVID includes clinically and genetically heterogeneous disorders characterized by a defect in B cell differentiation leading to inadequate antibody responses and low levels of immunoglobulin G (IgG) and IgA, and, inconsistently, also IgM. This evidence concerns the gene CD79A and common variable immunodeficiency.